FDA Warning Letter — Hemofarm AD Vrsac
The FDA took a Warning Letter action against Hemofarm AD Vrsac on June 20, 2012 (Vrsac, Serbia). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- Hemofarm AD Vrsac
- Date
- June 20, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Center
- CDER
- Location
- Vrsac (Serbia)